Optimization and production of single-shot vaccines for melioidosis and glanders
Active Definitive Contract Awarded Last action
- Contract number
- HDTRA123C0009
- Awardee
-
Vitrivax, Inc. UEI VFTQREMA1CZ4
- Awarding agency
-
Defense Threat Reduction Agency
Department of Defense
- Obligated
- $14,508,296
Award facts
- Opportunity
-
- Science and Technology New Initiatives BAA Solicitation · HDTRA117S0002 · Posted Nov 2, 2016
- Contract value 49% obligated
-
- $15,664,139.20 Current, with exercised options
- $29,845,804.71 Potential, with all options
- Completion date 76% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Boulder, CO 80301, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $1,407,500 | |
| Exercise an Option | $4,000,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Vendor Address Change | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $3,242,467 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $2,248,285 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $822,808 | |
| Supplemental Agreement for work within scope | $1,393,618 | |
| Funding Only Action | $737,497 | |
| Original award | $656,121 |
Show all 14
About this award
The Defense Threat Reduction Agency awarded a definitive contract to Vitrivax, Inc. for optimization and production of single-shot vaccines for melioidosis and glanders on January 12, 2023, with a ceiling value of $29.8 million under cost-plus-fixed-fee pricing and no set-aside.
Place of performance is Boulder, Colorado. The originating solicitation was a Broad Agency Announcement posted November 2, 2016, seeking innovative research and development projects focused on countering weapons of mass destruction across six technology areas at Technology Readiness Levels 2 through 6. Performance was to occur within the United States over a potential six-year timeframe through October 2021, with selected awards eligible for extension up to five years. Ultimate completion date is January 11, 2028.
Quick answers
Who was awarded contract HDTRA123C0009?
HDTRA123C0009 was awarded to Vitrivax, Inc. by Defense Threat Reduction Agency (Department of Defense) on January 12, 2023.
How much is contract HDTRA123C0009 worth?
The government has obligated $14,508,296 on HDTRA123C0009. Its current value, with exercised options, is $15,664,139. Its potential value, with all options, is $29,845,805.
Was contract HDTRA123C0009 competed?
The extent of competition for HDTRA123C0009 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award